Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Here's Why

Veradigm logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares of Veradigm (NASDAQ:MDRX) gapped up premarket, opening at $4.60 versus the prior close of $4.40 on very light volume (479 shares).
  • Wall Street Zen upgraded Veradigm to a "hold" rating on March 7.
  • Veradigm, a healthcare technology company offering EHR and revenue-cycle solutions, has a market cap of $495.5M, a P/E of 23.25, and 50-/200-day moving averages of $4.55/$4.68.
  • Five stocks to consider instead of Veradigm.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped up prior to trading on Tuesday . The stock had previously closed at $4.40, but opened at $4.60. Veradigm shares last traded at $4.60, with a volume of 479 shares.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Veradigm to a "hold" rating in a report on Saturday, March 7th.

Check Out Our Latest Research Report on Veradigm

Veradigm Stock Performance

The company's fifty day moving average is $4.55 and its two-hundred day moving average is $4.68. The company has a market cap of $495.50 million, a price-to-earnings ratio of 23.25 and a beta of 0.56.

About Veradigm

(Get Free Report)

Veradigm, Inc NASDAQ: MDRX is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company's offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm's product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines